Skip to main content
. 2013 Oct 1;10(10):e1001524. doi: 10.1371/journal.pmed.1001524

Table 2. Assessment of balance in recruitment, enrollment, measurement, coverage of the intervention, and early postpartum hemorrhage (PPH) treatment between groups.

Recruitment/Enrollment Indicator Oxytocin Control
Among all women approached (n, %)
Refused initial consent 2 (0.1) 1 (0.0)
Agreed to initial consent 2,402 (99.9) 3,514 (100.0)
Among all participating pregnancies
Called community health officer (CHO) or field worker (FW) 1,146 (47.7) 539 (43.8)
Did not call 1,256 (52.3) 1,975 (56.2)
Among those that called CHO or FW
Enrolled 689 (60.3) 897 (58.3)
Not enrolled - CHO late or did not arrive 255 (22.3) 450 (29.2)
Not enrolled - referred before delivery 198 (17.3) 192 (12.5)
Measurement Indicators
Status of placing the drape
Before delivery 618 (90.0) 593 (66.3)
After delivery, before placenta 58 (8.4) 278 (31.1)
After delivery of placenta 4 (0.6) 12 (1.3)
Not tied/missing 7 (1.0) 11 (1.2)
Time between delivery and unfolding of the drape (minutes) (m, SD) 3.4 (5.4) 4.4 (5.7)
Portion of first hour spent lying on back after drape applied
60 minutes 649 (96.4) 855 (98.2)
50–59 minutes 11 (1.6) 9 (1.0)
40–49 minutes 10 (1.5) 4 (0.5)
<40 minutes 3 (0.4) 3 (0.3)
Quantitative blood measurement available (i.e., is PPH-1 defined)?
No 7 (1.0) 10 (1.1)
Yes 682 (99.0) 887 (98.9)
Intervention Characteristics
Received prophylactic injection
No 12 (1.7) 896 (99.9)
Yes 677 (98.3) 1 (0.1)
Timing of prophylactic injection
Not received 12 (1.7) 896 (99.9)
After delivery, before placenta 667 (96.9) 1 (0.1)
After delivery, after placenta 9 (1.3) 0 (0.0)
Location of prophylactic injection
Not received 12 (1.7) 896 (99.9)
Thigh 677 (98.3) 1 (0.1)
Time to prophylactic intervention (minutes) (m, SD) 1.79 (3.4) 21.00 (0.0)
Early PPH Treatment
Among all women with PPH-3 (n, %)
Received early treatment of oxytocin (10 IU) 24 (85.7) 90 (90.9)
Did not receive early PPH treatment 4 (14.3) 9 (9.1)